• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    argenx SE - American Depositary Shares (NQ:ARGX)

    958.91 -11.75 (-1.21%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 243,748
    Open 970.08
    Bid (Size) 870.00 (40)
    Ask (Size) 1,111.00 (40)
    Prev. Close 970.66
    Today's Range 952.27 - 970.27
    52wk Range 661.85 - 1,072.75
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
    From argenx SE
    Via GlobeNewswire
    News headline image
    Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months ↗
    There are good reasons behind analyst's bullish views of this biotech stock. 
    Via The Motley Fool

    Performance

    YTD
    +14.2%
    +14.2%
    1 Month
    -7.1%
    -7.1%
    3 Month
    +5.4%
    +5.4%
    6 Month
    +29.0%
    +29.0%
    1 Year
    +30.0%
    +30.0%

    More News

    Read More
    News headline image
    2 Wall Street Analysts Think Argenx Can Soar More Than 40%. Here's Why They're Right. ↗
    Via The Motley Fool
    News headline image
    argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors
    From argenx SE
    Via GlobeNewswire
    ARGENX SE - ADR (NASDAQ:ARGX) Meets Minervini Trend Template and High Growth Momentum ↗
    Via Chartmill
    News headline image
    Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today ↗
    Via Benzinga
    News headline image
    Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated? ↗
    Via The Motley Fool
    News headline image
    argenx to Present at Upcoming Investor Conferences
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Completes Acquisition of Forte Biosciences, Inc.
    From argenx SE
    Via GlobeNewswire
    News headline image
    Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story ↗
    Via The Motley Fool
    News headline image
    Snowflake To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
    Via Benzinga
    News headline image
    These Analysts Boost Their Forecasts On Argenx ↗
    Via Benzinga
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing ↗
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    $100 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗
    Via Benzinga
    News headline image
    argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
    From argenx SE
    Via GlobeNewswire
    News headline image
    Here’s How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗
    Via Benzinga
    News headline image
    argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102 ↗
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenex Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings Intellectual Property
    News headline image
    argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026
    From argenx SE
    Via GlobeNewswire

    Frequently Asked Questions

    Is argenx SE - American Depositary Shares publicly traded?
    Yes, argenx SE - American Depositary Shares is publicly traded.
    What exchange does argenx SE - American Depositary Shares trade on?
    argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for argenx SE - American Depositary Shares?
    The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
    What is the current price of argenx SE - American Depositary Shares?
    The current price of argenx SE - American Depositary Shares is 958.91
    When was argenx SE - American Depositary Shares last traded?
    The last trade of argenx SE - American Depositary Shares was at 09/30/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.